The Association of Migraine Disorders (AMD) is devoted to expanding the understanding of migraine disease and its true scope. Migraine is a full body condition with a broad spectrum of symptoms, AMD is focused on including many medical specialties in the management of this disease.

Learn more

View more/less

Theranica develops advanced yet affordable electroceuticals, addressing a few prevalent neurological pain diseases. The company’s first FDA-authorized product, Nerivio™, is available in the US. Nerivio is an innovative, non-invasive, smartphone-operated, prescribed wearable for the acute treatment of migraine. 12% of the world’s population suffer from migraine, of which 80% are women. Being completely drug-free, Nerivio™ is a safe, addiction-free alternative in the multi-billion-dollar market of medications for migraine.

Learn more

View more/less

Summaries now available for every interview with expert quotes, treatments mentioned, action items. Start making positive changes today with these guides. Only available with 2020 VIP Access Pass.

View more/less

Today's Interviews

The Latest New Treatment Innovations

Peter Goadsby, MD

Professor of Neurology and Headache Specialist
King's College London, UK

Are Migraine Surgeries Worth It?

William B. Young, MD

Neurologist and Headache Specialist
Jefferson Headache Center

Real-World Use of CGRP Medications

Brian Grosberg, MD

Director and Headache Specialist
Hartford HealthCare Headache Center

Multi-Disciplined Approach to Migraine Management

Tine Poole, MD

Director
The Migraine Clinic, Norway

New Treatments

Timothy R. Smith, MD, RPH

President & CEO
StudyMetrix Research

Unlock full access to the entire 2020 Summit, including:

  • 30+ Expert interviews with audio clips and transcripts
  • Unlimited streaming and downloads
  • Lifetime access with no annual fee
Access Pass options
Loading...